ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY >
Analysis of Ultrasonic Manifestations of Pulmonary Lesions in Patients with COVID-19
Received date: 2020-03-30
Online published: 2020-04-18
Objectives: To analyze the progression manifestations and characteristics of pulmonary lesions in patients with COVID-19 by bed-side pulmonary ultrasonography.
Methods: A total of 20 COVID-19 patients admitted to the hospital from January to March in 2020 were retrospectively recruited. All cases were diagnosed according to the "Novel Coronavirus Pneumonia Treatment Protocol (Trial 7th edition)". The imaging characteristics of bed-side pulmonary ultrasonography were analyzed and summarized during the different disease stages.
Results: The average course of disease was 21.2 days, including 10.5 days of the progression period and 10.7 days of the recovery period. The ultrasound images of the patients were mainly presented as unsmoothed or interrupted pleural line, and B-line distribution was observed in all cases (20/20,100%). The "inflatable signs" in the consolidation lesion were visualized in 16 cases (16/20, 75.00%). In progressive stage, the ultrasound image changed from B-line sign to sieve-like consolidation, then the consolidation aggravated from patchy to chunk-like gradually, with the decreasing air bronchogram sign within the consolidation lesion. While the imaging characteristics of the ultrasound in the recovery stage were opposite to the progress stage, Color mode showed that the perfusion in the lesions of consolidation gradually increased as well.
Conclusion: The ultrasonic manifestations of COVID-19 patients had certain characteristics in the different disease stages. The application of ultrasound in these patients could provide imaging evidence in evaluation of the disease courses and therapeutic efficacy.
Key words: COVID-19; Ultrasound; Diagnostic imaging; Disease characteristics
Huang, MD Yi , Wang, MD Hua , Cui, MD Wenqi , Zong, MD Yujin , Zheng, MD Chuyun , Liu, MD Yue , Min, MD Weili , Wang, MD Sihan , Hu, MD Mingjun , Zhang, MD Yaohui . Analysis of Ultrasonic Manifestations of Pulmonary Lesions in Patients with COVID-19[J]. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY, 2020 , 4(2) : 73 -78 . DOI: 10.37015/AUDT.2020.200034
[1] | Wujtewicz M, Dylczyk-Sommer A, Aszkie?owicz A, Zdanowski S, Piwowarczyk S, Owczuk R. COVID-19 - what should anaethesiologists and intensivists know about it? Anaesthesiol Intensive Ther 2020; 52:34-41. |
[2] | Wang W, Tang J, Wei F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J Med Virol 2020; 92:441-447. |
[3] | Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet 2020; 395:931-934. |
[4] | European Centre for Disease Prevention and Control. Situation update worldwide, as of 7 March 2020, 08:00. Available from: https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases |
[5] | World Health Organization. Coronavirus disease (COVID-2019) situation reports[Accessed 18 March 2020]. Available from:https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ |
[6] | Lei J, Li J, Li X, Qi X. CT imaging of the 2019 novel coronavirus (2019-nCoV) pneumonia. Radiology. 2020 Apr; 295(1):18. DOI: 10.1148/radiol.2020200236. |
[7] | Tian S, Hu W, Niu L, Liu H, Xu H, Xiao SY. Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020 Feb 28. DOI: 10.1016/j.jtho.2020.02.010. |
[8] | Buonsenso D, Piano A, Raffaelli F, Bonadia N, de Gaetano Donati K, Franceschi F. Point-of-care lung ultrasound findings in novel coronavirus disease-19 pnemoniae: a case report and potential applications during COVID-19 outbreak. Eur Rev Med Pharmacol Sci 2020; 24:2776-2780. |
/
〈 | 〉 |